Lynch & Associates Merck & Co., Inc. Transaction History

Lynch & Associates

$429 Million
Q1 2024

A detailed history of Lynch & Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lynch & Associates holds 90,185 shares of MRK stock, worth $11.3 Million. This represents 2.77% of its overall portfolio holdings.

Number of Shares

90,185

Previous 94,616 4.68%

Holding current value

$11.3 Million

Previous $10.3 Million 15.36%

% of portfolio

2.77%

Previous 2.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$113.24 - $131.95 $501,766 - $584,670	-4,431 Reduced 4.68%	90,185 $11.9 Million
Q4 2023 Jan 08, 2024	SELL	$100.18 - $109.02 $169,504 - $184,461	-1,692 Reduced 1.76%	94,616 $10.3 Million
Q3 2023 Oct 24, 2023	SELL	$102.95 - $114.33 $327,381 - $363,569	-3,180 Reduced 3.2%	96,308 $9.91 Million
Q2 2023 Oct 24, 2023	SELL	$108.61 - $118.38 $36,492 - $39,775	-336 Reduced 0.34%	99,488 $11.5 Million
Q2 2023 Jul 13, 2023	SELL	$108.61 - $118.38 $36,492 - $39,775	-336 Reduced 0.34%	99,488 $11.5 Million

Q1 2023 Oct 24, 2023	BUY	$102.94 - $114.86 $34,587 - $38,592	336 Added 0.34%	99,824 $10.6 Million
Q1 2023 Apr 04, 2023	SELL	$102.94 - $114.86 $155,645 - $173,668	-1,512 Reduced 1.49%	99,824 $10.6 Million
Q4 2022 Oct 24, 2023	BUY	$87.44 - $112.11 $439,648 - $563,689	5,028 Added 5.22%	101,336 $11.2 Million
Q4 2022 Jan 05, 2023	SELL	$87.44 - $112.11 $316,270 - $405,501	-3,617 Reduced 3.45%	101,336 $11.2 Million
Q3 2022 Oct 03, 2022	BUY	$84.53 - $94.96 $55,282 - $62,103	654 Added 0.63%	104,953 $9.04 Million
Q2 2022 Jul 06, 2022	SELL	$83.49 - $94.64 $78,063 - $88,488	-935 Reduced 0.89%	104,299 $9.51 Million
Q1 2022 Apr 08, 2022	BUY	$73.51 - $82.4 $12,055 - $13,513	164 Added 0.16%	105,234 $8.63 Million
Q4 2021 Jan 11, 2022	BUY	$72.28 - $90.54 $206,865 - $259,125	2,862 Added 2.8%	105,070 $8.05 Million
Q3 2021 Oct 12, 2021	BUY	$71.68 - $78.83 $177,264 - $194,946	2,473 Added 2.48%	102,208 $7.68 Million
Q2 2021 Jul 21, 2021	SELL	$70.31 - $77.77 $83,247 - $92,079	-1,184 Reduced 1.17%	99,735 $7.76 Million
Q1 2021 Apr 09, 2021	SELL	$68.86 - $81.11 $157,551 - $185,579	-2,288 Reduced 2.22%	100,919 $7.78 Million
Q4 2020 Jan 20, 2021	BUY	$71.77 - $79.65 $62,942 - $69,853	877 Added 0.86%	103,207 $8.44 Million
Q3 2020 Oct 21, 2020	SELL	$73.18 - $82.95 $33,150 - $37,576	-453 Reduced 0.44%	102,330 $8.49 Million
Q2 2020 Jul 20, 2020	SELL	$70.42 - $80.13 $148,867 - $169,394	-2,114 Reduced 2.02%	102,783 $7.95 Million
Q1 2020 Apr 28, 2020	SELL	$63.36 - $87.82 $506 - $702	-8 Reduced 0.01%	104,897 $8.07 Million
Q4 2019 Jan 10, 2020	BUY	$77.58 - $87.54 $398,373 - $449,517	5,135 Added 5.15%	104,905 $9.54 Million
Q3 2019 Oct 03, 2019	BUY	$76.08 - $82.93 $48,386 - $52,743	636 Added 0.64%	99,770 $8.4 Million
Q2 2019 Jul 19, 2019	SELL	$69.84 - $81.59 $80,455 - $93,991	-1,152 Reduced 1.15%	99,134 $8.31 Million
Q1 2019 Apr 25, 2019	BUY	$69.58 - $79.36 $88,853 - $101,342	1,277 Added 1.29%	100,286 $8.34 Million
Q4 2018 Jan 10, 2019	BUY	$65.24 - $75.71 $22,703 - $26,347	348 Added 0.35%	99,009 $7.57 Million
Q3 2018 Oct 05, 2018	SELL	$57.69 - $67.84 $114,687 - $134,865	-1,988 Reduced 1.98%	98,661 $7 Million
Q2 2018 Jul 09, 2018	BUY	$50.83 - $59.72 $412,637 - $484,806	8,118 Added 8.77%	100,649 $6.11 Million
Q1 2018 Apr 06, 2018	SELL	$50.96 - $59.23 $5,452 - $6,337	-107 Reduced 0.12%	92,531 $5.04 Million
Q4 2017 Jan 04, 2018	SELL	$51.62 - $61.64 $211,538 - $252,600	-4,098 Reduced 4.24%	92,638 $5.21 Million
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $5.68 Million - $6.11 Million	96,736	96,736 $6.19 Million

Others Institutions Holding MRK

# of Institutions

3,773

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $317B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Account

Lynch & Associates Merck & Co., Inc. Transaction History